ESPERITE N.V. announces the voting results for the Extra-ordinary General Meeting of Shareholders of ESPERITE N.V. held on Wednesday 30 September 2020.

October 5, 2020 Group News
Financial and business update

Esperite announces the voting results for EGM

The Netherlands – 5 October 2020

Voting results are set out below:

Number of shares represented at the meeting: 11’070’877

Percentage of issued share capital as per the registration date: 14.33%

 

Agenda item – Resolution # votes % votes For Against Abstain Result
Agenda item 2

Approval Minutes of the Annual General Meeting of Shareholders of 8 January 2019

11’070’877 14.33% 10’346’865 2’001 722’011 Adopted
Agenda item 5

Delegation to the Board of Directors of the powers to issue, and grant rights to subscribe for, shares in the capital of the Company and to restrict or exclude pre-emptive rights accruing in connection with such issue of shares or grant of rights to subscribe for shares

11’070’877 14.33% 10’351’255 11 719’611 Adopted
Agenda Item 6

Proposal to reduce the share capital with EUR 15,750,000 by means of reducing the nominal value of the shares from EUR 0.10 to EUR 0.01 per share

11’070’877 14.33% 10’350’495 771 719’611 Adopted
Agenda item 7

Amendment of article 4 of the Articles of Association

11’070’877 14.33% 10’351’255 11 719’611 Adopted
Agenda item 8

(i) Appointment of Mr. Hugo Brugiere as executive director, CEO of the Company for a maximum period of four years or until the AGM to be held in 2024

11’070’877 14.33% 10’351’255 11 719’611 Adopted
Agenda item 8

(ii) Re-appointment of Mr. Gert-Jan van der Marel as non-executive director of the Company for a maximum period of four years or until the AGM to be held in 2024

11’070’877 14.33% 10’348’855 11 722’011 Adopted
Agenda item 8

(iii) Appointment of Mr. Amar as non-executive director of the Company for a maximum period of four years or until the AGM to be held in 2024

11’070’877 14.33% 10’351’255 11 719’611 Adopted
Agenda item 9

Discharge of the former members of the Board of Directors

11’070’877 14.33% 10’349’255 569’621 152’001 Adopted
Agenda item 10

Proposal to approve, confirm and ratify the entering into the strategic license agreement

11’070’877 14.33% 10’346’855 11 724’011 Adopted

 

***

About ESPERITE

ESPERITE is a diversified investment company group. Established in 2000, Esperite is a holding company, listed at Euronext Amsterdam and Paris. ESPERITE invests in companies able to transform the power of state-of-the-art technologies and scientific advancements into high quality products.

To learn more about the ESPERITE Group, or to book an interview with the CEO Frederic Amar: info@esperitegroup.com or visit the websites at www.esperite.com

 ***






***

This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).

With respect to Member States of the European Economic Area that have transposed European Directive 2003/71/EC of the European Parliament and European Council (as amended in particular by Directive 2010/73/EU to the extent that the said Directive has been transposed into each Member State of the European Economic Area), no action has been taken or will be taken to permit a public offering of the securities referred to in this press release requiring the publication of a prospectus in any Member State.

This press release and the information it contains do not, and will not, constitute an offer to subscribe for or sell, nor the solicitation of an offer to subscribe for or buy, securities of Esperite in the United States of America or any other jurisdiction. Securities may not be offered or sold in the United States of America absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), it being specified that the securities of Esperite have not been and will not be registered within the US Securities Act. Esperite does not intend to register securities or conduct a public offering in the United States of America.

***



Related Articles